Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Ritchlin

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
Current Rheumatology Reports|September 28, 2013
Mechanistic insights from animal models of psoriasis and psoriatic arthritisJoshua E Weitz, Christopher T Ritchlin
Expert Opinion on Biological Therapy|February 22, 2014
Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritisJoshua E Weitz, Christopher T Ritchlin
Arthritis Research & Therapy|July 20, 2007
Clinical development of anti-RANKL therapyEdward M Schwarz, Christopher T Ritchlin
Journal of Cellular Physiology|March 29, 2016
DC-STAMP: A Key Regulator in Osteoclast DifferentiationYa-Hui Chiu, Christopher T Ritchlin
Postgraduate Medicine|December 8, 2004
Treatment update on spondyloarthropathy. From NSAIDs and DMARDs to anti-TNF-alpha agentsAllen P Anandarajah, Christopher T Ritchlin
Current Opinion in Rheumatology|March 30, 2016
New therapies for psoriasis and psoriatic arthritisChristopher T Ritchlin, James G Krueger
Current Opinion in Rheumatology|June 18, 2004
Pathogenesis of psoriatic arthritisAllen P Anandarajah, Christopher T Ritchlin
The Journal of Rheumatology|May 26, 2006
Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelinesArthur F Kavanaugh, Christopher T Ritchlin,
Current Rheumatology Reports|September 16, 2006
Metabolic disorders in patients with psoriasis and psoriatic arthritisLotus Mallbris, Christopher T Ritchlin, Mona Ståhle
Psoriasis Forum|November 28, 2014
Biomarkers to Diagnose Early Arthritis in Patients With PsoriasisYa-Hui Grace Chiu, Christopher T Ritchlin
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
Current Rheumatology Reports|September 28, 2013
Mechanistic insights from animal models of psoriasis and psoriatic arthritisJoshua E Weitz, Christopher T Ritchlin
Expert Opinion on Biological Therapy|February 22, 2014
Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritisJoshua E Weitz, Christopher T Ritchlin
Arthritis Research & Therapy|July 20, 2007
Clinical development of anti-RANKL therapyEdward M Schwarz, Christopher T Ritchlin
Journal of Cellular Physiology|March 29, 2016
DC-STAMP: A Key Regulator in Osteoclast DifferentiationYa-Hui Chiu, Christopher T Ritchlin
Postgraduate Medicine|December 8, 2004
Treatment update on spondyloarthropathy. From NSAIDs and DMARDs to anti-TNF-alpha agentsAllen P Anandarajah, Christopher T Ritchlin
Current Opinion in Rheumatology|March 30, 2016
New therapies for psoriasis and psoriatic arthritisChristopher T Ritchlin, James G Krueger
Current Opinion in Rheumatology|June 18, 2004
Pathogenesis of psoriatic arthritisAllen P Anandarajah, Christopher T Ritchlin
The Journal of Rheumatology|May 26, 2006
Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelinesArthur F Kavanaugh, Christopher T Ritchlin,
Current Rheumatology Reports|September 16, 2006
Metabolic disorders in patients with psoriasis and psoriatic arthritisLotus Mallbris, Christopher T Ritchlin, Mona Ståhle
Psoriasis Forum|November 28, 2014
Biomarkers to Diagnose Early Arthritis in Patients With PsoriasisYa-Hui Grace Chiu, Christopher T Ritchlin
Pageof 22